Fresenius Kabi a good bet, says Ashish Tater, Fort Share Broking.
Tater told CNBC TV18, “The stock for the day is Fresenius Kabi Oncology. One stock where we feel there could be an open offer from Fresenius Kaby Singapore a subsidiary of Fresenius Kabi Germany. It holds lot of synergy with another company of Fresenius Kabi Germany, ATP Pharmaceuticals.”
He further added, “This stock could be delisted somewhere around Rs 192- Rs 225 because the fair value of the stock can be anywhere around Rs 130- Rs 150 on a long term scale plus Rs 60-70 of synergetic value. I think this is one bet which can be taken on for an intraday target of Rs 132.50 and medium term target of Rs 155-Rs 160 odd levels.”
Set email alert for
ADS BY GOOGLE
video of the day
Mkt resilient at current level; bullish auto: ICICI Pru AMC